Supply chains have key role to play in global vaccine equity conversation

8

The pharmaceutical industry has a complex global supply chain. One that requires regulatory scrutiny, a raft of compliance checks, as well as the challenges associated with transporting products that are often both temperature and humidity sensitive. As the international case for vaccine equity gains momentum, there is a recognition of the need for better distribution of vital medications – particularly in less economically developed countries (1).